Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. Good afternoon. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley, and thanks for joining us for our next session. Very pleased to have BioMarin with us. Briefly before we get started, I need to read a disclosure.
Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately.
For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley representatives.
So with that, I'm very pleased to have 3 members of the management team from BioMarin. J.J. Bienaimé, who's the CEO; Hank Fuchs, who runs R&D; and Brian Mueller, who's the CFO. And J.J., I'm going to turn it over to you to make some opening remarks, and then we'll jump into Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
